YH, K., & CH, H. (2026). Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma-A Step Toward Mechanism-Guided Second-Line Therapy. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.70604
Chicago Style (17th ed.) CitationYH, Kuo, and Hung CH. "Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma-A Step Toward Mechanism-Guided Second-Line Therapy." Alimentary Pharmacology & Therapeutics 2026. https://doi.org/10.1111/apt.70604.
MLA (9th ed.) CitationYH, Kuo, and Hung CH. "Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma-A Step Toward Mechanism-Guided Second-Line Therapy." Alimentary Pharmacology & Therapeutics, 2026, https://doi.org/10.1111/apt.70604.
Warning: These citations may not always be 100% accurate.
